Xconomy National

Archives

by in

Entry	Author	Date	Location
Alnylam Cuts One-Third of Workforce, To Save Cash for RNAi Clinical Plans	Luke Timmerman	01/19/12	Boston
San Diego Life Sciences News: AnaptysBio, Life, NeuroGenetic & More	Bruce V. Bigelow	01/12/12	San Diego
Foundation Medicine and Sanofi Form Cancer Discovery Pact	Arlene Weintraub	01/10/12	Boston
Forma Cuts $65M Deal With Boehringer Ingelheim to Discover Cancer Drugs	Luke Timmerman	01/05/12	Boston
Allozyne Raises More VC Cash, Looks to FDA Meeting After Poniard Deal Fizzles	Luke Timmerman	12/23/11	Seattle
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups	Luke Timmerman	12/22/11	Seattle
Millennium: Takeda Acquires San Diego’s Intellikine for $190M Upfront	Luke Timmerman	12/20/11	Boston
Ariad’s Second Cancer Drug Found Safer Than Expected in Early Review of Key Study	Luke Timmerman	11/07/11	Boston
Biopharma Industry Meetings Could Use Some Fresh Voices	Stewart Lyman	11/01/11	Seattle
The Cancer Drug Dark Ages Are Coming to an End	Luke Timmerman	10/31/11	National
Portola Grabs $45M Upfront From Biogen Idec to Develop Autoimmune Drugs	Luke Timmerman	10/27/11	San Francisco
Synthetic Genomics Spins Out Another Startup, Agradis, Focused on Agricultural Biotechnology	Bruce V. Bigelow	10/24/11	San Diego
Kleiner Perkins, Google Ventures Join Expanded $33.5M Round for Foundation Medicine	Luke Timmerman	10/18/11	Boston
Tokai Gets $23M, Eleven Therapeutics Hires New CEO, Ariad Drug Advances, & More Boston-Area Life Sciences News	Erin Kutz	09/23/11	Boston
Eleven Biotherapeutics Dials Up New CEO, Primes Lead Eye Drug for Clinic Next Year	Luke Timmerman	09/22/11	Boston
Merck Joins the Big Pharma VC Party, Setting Up $250M Biotech Investment Fund	Luke Timmerman	09/15/11	National
Dendreon Slashes 500 Jobs, Gates Foundation Adds Novartis Exec, Theraclone Tacks on $10M, & More Seattle-Area Life Sciences News	Luke Timmerman	09/15/11	Seattle
Gates Foundation Adds Novartis Vet, Trevor Mundel, as New Global Health Leader	Luke Timmerman	09/13/11	Seattle
Verizon’s Software Beachhead in Boston: The Story Behind CloudSwitch and Terremark	Gregory T. Huang	08/26/11	Boston
Foundation Medicine Grabs $10M	Erin Kutz	08/23/11	Boston
Quanterix Finds $6M	Erin Kutz	08/23/11	Boston
Cerulean Shows Progress in Cancer, Tests Nano-Drug Platform in RNAi	Arlene Weintraub	07/27/11	Boston
Bristol-Myers Acquires Amira Pharmaceuticals for $325 Million, Scoops Up Lung Drug	Luke Timmerman	07/21/11	San Diego
Encouraged by Early Work on Anti-Cancer Drug, Intellikine Hires New Head for Clinical Trials	Bruce V. Bigelow	07/18/11	San Diego
Allozyne Looks to Rustle Up Interest on Wall Street With Backdoor IPO	Luke Timmerman	07/13/11	Seattle
Idera Takes Beating on Loss of Merck KGaA Cancer Collaboration, But Remains Committed to Toll-Like Receptors	Arlene Weintraub	07/13/11	Boston
Seattle Genetics, On the Verge of Going Commercial, Seeks to Keep Its Scientific Soul	Luke Timmerman	07/05/11	Seattle
Alnylam Looks to ASCO as First “Bell-Ringing” for RNAi Resurgence	Arlene Weintraub	05/26/11	Boston
Foundation Medicine Teams With Celgene in Quest to Develop Targeted Cancer Treatments	Arlene Weintraub	05/17/11	New York
Drugs that Melt in Your Mouth: MonoSolRx Has Its Sights Set on Oral Insulin	Arlene Weintraub	05/11/11	New York
Page 1 of 9	next page »